Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma ; volume:5 ; number:5 ; year:2018 ; extent:12
Advanced science ; 5, Heft 5 (2018) (gesamt 12)
- Creator
-
Zhang, Yi
Wang, Feng
Li, Mingqiang
Yu, Zhiqiang
Qi, Ruogu
Ding, Jianxun
Zhang, Zhiyu
Chen, Xuesi
- DOI
-
10.1002/advs.201700821
- URN
-
urn:nbn:de:101:1-2022091008151181320725
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Yi
- Wang, Feng
- Li, Mingqiang
- Yu, Zhiqiang
- Qi, Ruogu
- Ding, Jianxun
- Zhang, Zhiyu
- Chen, Xuesi
Other Objects (12)
Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
SAHA (Vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines
Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin
Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better?
Biomimetic Targeted Co‐Delivery System Engineered from Genomic Insights for Precision Treatment of Osteosarcoma
The effect of doxorubicin curcumin co-loaded lipid nanoparticles and doxorubicin on osteosarcoma before surgery
A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells
Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells
Reprogramming tumor microenvironment via dual targeting co-delivery of regorafenib and alpha-difluoromethylornithine in osteosarcoma
Oxidative stress induction by narasin augments doxorubicin’s efficacy in osteosarcoma
Black phosphorus quantum dots camouflaged with platelet-osteosarcoma hybrid membrane and doxorubicin for combined therapy of osteosarcoma
The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
SAHA (Vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines
Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin
Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better?
Biomimetic Targeted Co‐Delivery System Engineered from Genomic Insights for Precision Treatment of Osteosarcoma
The effect of doxorubicin curcumin co-loaded lipid nanoparticles and doxorubicin on osteosarcoma before surgery
A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells
Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells
Reprogramming tumor microenvironment via dual targeting co-delivery of regorafenib and alpha-difluoromethylornithine in osteosarcoma
Oxidative stress induction by narasin augments doxorubicin’s efficacy in osteosarcoma
Black phosphorus quantum dots camouflaged with platelet-osteosarcoma hybrid membrane and doxorubicin for combined therapy of osteosarcoma
The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
SAHA (Vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines
Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin
Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better?
Biomimetic Targeted Co‐Delivery System Engineered from Genomic Insights for Precision Treatment of Osteosarcoma
The effect of doxorubicin curcumin co-loaded lipid nanoparticles and doxorubicin on osteosarcoma before surgery
A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells
Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells
Reprogramming tumor microenvironment via dual targeting co-delivery of regorafenib and alpha-difluoromethylornithine in osteosarcoma
Oxidative stress induction by narasin augments doxorubicin’s efficacy in osteosarcoma
Black phosphorus quantum dots camouflaged with platelet-osteosarcoma hybrid membrane and doxorubicin for combined therapy of osteosarcoma